Clinical research isn’t a straight path.

Let’s navigate it together.

Worldwide Clinical Trials is a leading full-service global CRO that works in partnership with biotechnology and pharmaceutical companies to create customized solutions that advance new medications – from discovery to reality.

Want a CRO partner who gives you their full attention?

You’re in the right place.

Watch Video
0 +

Therapeutic Experts

0 +

Countries, All Regions

Accessible partners.

We are where you need us, when you need us. Worldwide is your extended team and is always within reach, including our senior-level experts who will work directly with you.

Shared commitment.

We believe working together to harness great ideas will lead us to a healthier world. Every study is different. Every path forward is different. And we will partner with you every step of the way.

Personalized for you.

We were founded on an unwavering commitment to therapeutic excellence and personalized attention. And today, that’s more important than ever.

0 +

Therapeutic Experts

0

Locations

0 +

Countries, All Regions

Comprehensive clinical development services across all phases

Anchored in our company’s scientific heritage, we are therapeutically focused on neuroscience, cardiometabolic & inflammatory diseases, oncology, and rare diseases with cross capabilities in rare and orphan methodology, cell and gene therapy, real world evidence, pediatrics, and biosimilars.

Icon list

Bioanalytical Services

  • Bioanalytical lab (Austin, TX)
  • AME Services
  • Assay Method Search
  • LC/MS/MS
  • Protein Binding
Icon list

Clinical Pharmacology Services

  • Phase 1 Clinical Trials
  • Bioequivalence
  • Clinical Pharmacology Unit (San Antonio, TX)
  • Pharmacokinetics
  • Pharmacodynamics
Icon list

Phase 2 – 3 Clinical Trials

  • Phase 2A-3 Clinical Trials
  • Feasibility / Protocol Development
  • Biostatistics
  • Clinical Monitoring & Site Management
  • Medical Monitoring
  • Data Management
  • Drug & Supply Depots
  • Drug Safety &Pharmacovigilance
  • Medical Writing
  • Method Development / Validation
  • Patient Recruitment / Retention
  • Project Management
  • Quality Assurance
  • Rater Services
  • Regulatory Affairs
Icon list

Phase 3 – 4 Clinical Trials

  • Phase 3-4 Clinical Trials
  • Drug Safety & Pharmacovigilance
  • Outcomes, Epidemiology & Risk Management
  • Registries & Observational Studies
Icon list

Worldwide Evidence™

  • Real-World Evidence
  • Evidence Strategy & Planning
  • Observational Studies / Patient Registry Services
  • Post-Approval Safety Studies

Our Experts

Mike Mencer

Executive Vice President and General Manager, Early Phase

Michael Murphy, MD, PhD

Chief Medical and Scientific Officer

Peter Benton, MBA

President and Chief Executive Officer

Henry J. Riordan, PhD

Chief Development Officer

Aman Khera, MBA, FTOPRA, FRAPS

VP, Regulatory Science, Strategy and Innovation

Client Testimonials

Hear from our past customers about their experience with Worldwide

“After working with Worldwide Clinical Trials for many years, it’s easy to see why they consistently perform so well in the ISR Phase II/III benchmarking report, especially in the areas of Overall Performance and Project Manager Quality. The Worldwide team has always been passionate about their work and the studies they conduct for their customers.”

Executive Vice President of Global Clinical Operations Veru Inc.

“Worldwide showed a true desire to partner with us during the bidding process, and that is exactly how it’s gone. I’ve lost count of the number of times I’ve needed someone and called them – and they are always there. It’s just so special the way it’s gone, and I trust them.”

Vice President, Disease Monitoring Programs Mid size biopharmaceutical customer

“We really appreciate the strong collaborative partnership we’ve developed with Worldwide which is based on shared accountability. I see us awarding them more studies in the future.”

Sr. Vice President of Clinical Development and CMS Clinical Stage Biotech Company

Awards

On May 1st, Industry Standard Research (ISR) announced the 2024 Leadership Awards, recognizing Phase 2/3 CROs for comprehensive excellence across their capabilities, compatibility, expertise, quality, and reliability.

In 2023, Worldwide Clinical Trials was named Most Innovative Clinical Research Organization (CRO) by the Triangle Business Journal (TBJ). This awards program celebrates the achievements of individuals and companies making critical advancements in pharmaceuticals, biotech, ag tech, and beyond, in the Triangle region of North Carolina.

Worldwide Clinical Trials, Inc., (Worldwide) the industry’s leading global, midsize, full-service contract research organization (CRO), has been recognized for excellence and honored in five categories in the 2022 CRO Leadership Awards, based on primary market research from Industry Standard Research (ISR) Reports and presented by Clinical Leader and Life Science Leader magazines. This marks the ninth consecutive year that Worldwide has been recognized as a high-performing CRO based on direct survey feedback from pharmaceutical and biotech professionals.

Over 80% of respondents agreed that midsize CROs, such as Worldwide, provide a strong cultural fit while being able to pivot quickly based on changing customer needs.

Read the full report here